UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

Diabetes, obesity & metabolism, 2011, Vol.13 (1), p.65-74

2011

Volltextzugriff (PDF)

Diabetic dyslipidaemia: from basic research to clinical practice

Diabetologia, 2003-06, Vol.46 (6), p.733-749

TASKINEN, M.-R

2003

Volltextzugriff (PDF)

Ectopic lipid storage and insulin resistance: a harmful relationship

Journal of internal medicine, 2013-07, Vol.274 (1), p.25-40

2013

Volltextzugriff (PDF)

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes

Diabetologia, 2006-09, Vol.49 (9), p.2049-2057

2006

Volltextzugriff (PDF)

Apolipoprotein B48 metabolism in chylomicrons and very low‐density lipoproteins and its role in triglyceride transport in normo‐ and hypertriglyceridemic human subjects

Journal of internal medicine, 2020-10, Vol.288 (4), p.422-438

2020

Volltextzugriff (PDF)

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study

Diabetologia, 2012-04, Vol.55 (4), p.915-925

2012

Volltextzugriff (PDF)

Overproduction of large VLDL particles is driven by increased liver fat content in man

Diabetologia, 2006-04, Vol.49 (4), p.755-765

2006

Volltextzugriff (PDF)

Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations

Diabetologia, 2009-04, Vol.52 (4), p.684-690

2009

Volltextzugriff (PDF)

Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study

Diabetologia, 2011-11, Vol.54 (11), p.2811-2819

2011

Volltextzugriff (PDF)

Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2011-04, Vol.13 (4), p.374-377

2011

Volltextzugriff (PDF)

The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with Type 2 diabetes

Diabetic medicine, 2013-06, Vol.30 (6), p.756-757

2013

Volltextzugriff (PDF)

Intestinal alkaline phosphatase at the crossroad of intestinal health and disease – a putative role in type 1 diabetes

Journal of internal medicine, 2017-06, Vol.281 (6), p.586-600

2017

Volltextzugriff (PDF)

Interaction of chylomicron remnants and VLDLs during ultracentrifuge separation based on the Svedberg flotation rate – Authors’ response

Journal of internal medicine, 2020-01, Vol.287 (1), p.118-118

2020

Volltextzugriff (PDF)

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial

The Lancet (British edition), 2007-11, Vol.370 (9600), p.1687-1697

2007

Volltextzugriff (PDF)

O04 Relation entre le métabolisme de l’apoA-II et celui des sous-fractions des VLDL: étude cinétique multicentrique chez 62 patients obèses avec syndrome métabolique

Diabetes & metabolism, 2015-03, Vol.41, p.A1-A2

2015

Volltextzugriff (PDF)

Kinetic studies to investigate lipoprotein metabolism

Journal of internal medicine, 2012-02, Vol.271 (2), p.166-173

2012

Volltextzugriff (PDF)

Linagliptin treatment in subjects with type 2 diabetes with and without mild-to-moderate renal impairment

Diabetes, obesity & metabolism, 2014-06, Vol.16 (6), p.560-568

2014

Volltextzugriff (PDF)

A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population

Obesity (Silver Spring, Md.), 2013-10, Vol.21 (10), p.2138-2145

2013

Volltextzugriff (PDF)

Long-term safety and efficacy of linagliptin as monotherapy or in combination with other oral glucose-lowering agents in 2121 subjects with type 2 diabetes: up to 2 years exposure in 24-week phase III trials followed by a 78-week open-label extension

International journal of clinical practice (Esher), 2012-08, Vol.66 (8), p.731-740

2012

Volltextzugriff (PDF)

Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes

Diabetologia, 2009-12, Vol.52 (12), p.2522-2530

2009

Volltextzugriff (PDF)

Deep subcutaneous adipose tissue is more saturated than superficial subcutaneous adipose tissue

International Journal of Obesity, 2013-04, Vol.37 (4), p.620-622

2013

Volltextzugriff (PDF)

Application of combined field Integral equation for electromagnetic scattering by dielectric and composite objects

IEEE transactions on antennas and propagation, 2005-03, Vol.53 (3), p.1168-1173

2005

Volltextzugriff (PDF)

Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men

Nutrition, metabolism, and cardiovascular diseases, 2017-06, Vol.27 (6), p.534-542

2017

Volltextzugriff (PDF)

Current and charge Integral equation formulation

IEEE transactions on antennas and propagation, 2006-01, Vol.54 (1), p.58-67

2006

Volltextzugriff (PDF)

1 – 25 von 1.170

Suche als RSS-Feed

Aktive Filter

ThemaRisk Factors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(981)
Mit Volltextzugriff
(934)

Publikationsform

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(729)
Life Sciences & Biomedicine
(626)
Humans
(583)
Male
(409)
Biological And Medical Sciences
(354)
Female
(337)
Medical Sciences
(324)
Middle Aged
(288)
Adult
(284)
Endocrinology & Metabolism
(142)
Aged
(129)
Triglycerides - Blood
(114)
Cardiovascular System & Cardiology
(112)
Medicin Och Hälsovetenskap
(107)
Animals
(104)
Adolescent
(95)
Cardiac & Cardiovascular Systems
(93)
Lipoproteins - Blood
(81)
Endocrinopathies
(78)
Child
(75)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(651)
Ingenta
(527)
EZB Electronic Journals Library
(521)
Journals@Ovid Full Text
(479)
Elsevier ScienceDirect Journals Complete
(335)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(237)
NUS Single-Journal Subscriptions
(223)
Wiley Online Library Journals
(172)
Wiley Online Library Full Collection 2018
(135)
IngentaConnect Journals
(118)
SpringerLink
(84)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(70)
Oxford Journals
(53)
Taylor & Francis Online
(46)
Taylor & Francis Current Content Access
(43)
Nature Journals
(40)
Oxford Journals 2020 Medicine
(38)
IEL
(36)
JSTOR
(34)
Nexis Uni
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

Diabetic dyslipidaemia: from basic research to clinical practice

Ectopic lipid storage and insulin resistance: a harmful relationship

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes

Apolipoprotein B48 metabolism in chylomicrons and very low‐density lipoproteins and its role in triglyceride transport in normo‐ and hypertriglyceridemic human subjects

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study

Overproduction of large VLDL particles is driven by increased liver fat content in man

Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations

Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study

Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes

The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with Type 2 diabetes

Intestinal alkaline phosphatase at the crossroad of intestinal health and disease – a putative role in type 1 diabetes

Interaction of chylomicron remnants and VLDLs during ultracentrifuge separation based on the Svedberg flotation rate – Authors’ response

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial

O04 Relation entre le métabolisme de l’apoA-II et celui des sous-fractions des VLDL: étude cinétique multicentrique chez 62 patients obèses avec syndrome métabolique

Kinetic studies to investigate lipoprotein metabolism

Linagliptin treatment in subjects with type 2 diabetes with and without mild-to-moderate renal impairment

A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population

Long-term safety and efficacy of linagliptin as monotherapy or in combination with other oral glucose-lowering agents in 2121 subjects with type 2 diabetes: up to 2 years exposure in 24-week phase III trials followed by a 78-week open-label extension

Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes

Deep subcutaneous adipose tissue is more saturated than superficial subcutaneous adipose tissue

Application of combined field Integral equation for electromagnetic scattering by dielectric and composite objects

Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men

ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

Current and charge Integral equation formulation

Aktive Filter

Suchergebnisse filtern